A Study of Chemotherapy with Experimental Crizotinib vs. Placebo For Non-Small Cell Lung Cancer After Surgery
Can targeted chemotherapy with Crizotinib, stop the growth of tumor cells by blocking the a protein from working?
ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7, Carcinoma, Lung Neoplasms, Non-Small-Cell Lung Carcinoma, Crizotinib, Tyrosine Protein Kinase Inhibitors, Clinical Observation, Laboratory Biomarker Analysis
Lead Scientist at UC Davis
- Tianhong Li
Associate Professor, Hematology and Oncology, School of Medicine. Authored (or co-authored) 65 research publications